Annual SG&A
$3.92 M
-$733.00 K-15.74%
31 December 2023
Summary:
Galmed Pharmaceuticals annual selling, general & administrative expenses is currently $3.92 million, with the most recent change of -$733.00 thousand (-15.74%) on 31 December 2023. During the last 3 years, it has fallen by -$205.00 thousand (-4.97%). GLMD annual SG&A is now -46.66% below its all-time high of $7.36 million, reached on 31 December 2013.GLMD Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.27 M
+$585.00 K+85.03%
30 September 2024
Summary:
Galmed Pharmaceuticals quarterly selling, general & administrative expenses is currently $1.27 million, with the most recent change of +$585.00 thousand (+85.03%) on 30 September 2024. Over the past year, it has increased by +$361.00 thousand (+39.58%). GLMD quarterly SG&A is now -81.87% below its all-time high of $7.02 million, reached on 31 December 2013.GLMD Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$779.78 M
-$6.32 M-0.82%
30 September 2024
Summary:
Galmed Pharmaceuticals TTM selling, general & administrative expenses is currently -$779.78 million, with the most recent change of -$6.32 million (-0.82%) on 30 September 2024. Over the past year, it has dropped by -$783.75 million (-19771.67%). GLMD TTM SG&A is now -2721.02% below its all-time high of $8.57 million, reached on 30 September 2014.GLMD TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLMD Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -15.7% | +39.6% | -10000.0% |
| 3 y3 years | -5.0% | -2.4% | -10000.0% |
| 5 y5 years | -11.6% | +33.6% | -10000.0% |
GLMD Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -30.7% | at low | -2.4% | +85.0% | -31.3% | at low |
| 5 y | 5 years | -30.7% | at low | -27.3% | +85.0% | -111.2% | at low |
| alltime | all time | -46.7% | +465.3% | -81.9% | +1380.2% | -2721.0% | at low |
Galmed Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.27 M(+85.0%) | $3.76 M(+10.6%) |
| June 2024 | - | $688.00 K(-10.2%) | $3.40 M(-9.9%) |
| Mar 2024 | - | $766.00 K(-25.6%) | $3.77 M(-3.9%) |
| Dec 2023 | $3.92 M(-15.7%) | $1.03 M(+12.9%) | $3.92 M(-1.0%) |
| Sept 2023 | - | $912.00 K(-14.1%) | $3.96 M(-5.4%) |
| June 2023 | - | $1.06 M(+15.6%) | $4.19 M(-2.1%) |
| Mar 2023 | - | $919.00 K(-14.2%) | $4.28 M(-8.1%) |
| Dec 2022 | $4.66 M(-17.8%) | $1.07 M(-6.0%) | $4.66 M(-3.3%) |
| Sept 2022 | - | $1.14 M(-1.0%) | $4.81 M(-3.3%) |
| June 2022 | - | $1.15 M(-11.3%) | $4.98 M(-4.3%) |
| Mar 2022 | - | $1.30 M(+5.5%) | $5.21 M(-8.1%) |
| Dec 2021 | $5.66 M(+37.1%) | $1.23 M(-5.8%) | $5.66 M(-1.5%) |
| Sept 2021 | - | $1.30 M(-5.2%) | $5.75 M(+4.5%) |
| June 2021 | - | $1.38 M(-21.5%) | $5.50 M(+10.7%) |
| Mar 2021 | - | $1.75 M(+33.0%) | $4.97 M(+20.3%) |
| Dec 2020 | $4.13 M(-1.6%) | $1.32 M(+25.0%) | $4.13 M(+1.3%) |
| Sept 2020 | - | $1.05 M(+24.7%) | $4.08 M(+2.5%) |
| June 2020 | - | $845.00 K(-7.3%) | $3.98 M(-8.3%) |
| Mar 2020 | - | $912.00 K(-27.9%) | $4.34 M(+3.4%) |
| Dec 2019 | $4.20 M(-5.5%) | $1.26 M(+32.7%) | $4.20 M(-4.5%) |
| Sept 2019 | - | $953.00 K(-21.0%) | $4.40 M(-0.8%) |
| June 2019 | - | $1.21 M(+56.5%) | $4.43 M(+2.4%) |
| Mar 2019 | - | $771.00 K(-47.4%) | $4.33 M(-2.5%) |
| Dec 2018 | $4.44 M | $1.47 M(+48.4%) | $4.44 M(-4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $987.00 K(-10.7%) | $4.66 M(+6.6%) |
| June 2018 | - | $1.10 M(+25.1%) | $4.37 M(+12.4%) |
| Mar 2018 | - | $883.00 K(-47.7%) | $3.89 M(+2.5%) |
| Dec 2017 | $3.80 M(+23.4%) | $1.69 M(+142.3%) | $3.80 M(+28.7%) |
| Sept 2017 | - | $697.00 K(+11.7%) | $2.95 M(+1.4%) |
| June 2017 | - | $624.00 K(-20.9%) | $2.91 M(-7.5%) |
| Mar 2017 | - | $789.00 K(-6.3%) | $3.15 M(+2.3%) |
| Dec 2016 | $3.08 M(-5.2%) | $842.00 K(+28.4%) | $3.08 M(+9.7%) |
| Sept 2016 | - | $656.00 K(-23.8%) | $2.81 M(+0.7%) |
| June 2016 | - | $861.00 K(+19.7%) | $2.79 M(-3.7%) |
| Mar 2016 | - | $719.00 K(+26.4%) | $2.89 M(-10.9%) |
| Dec 2015 | $3.25 M(+31.0%) | $569.00 K(-10.7%) | $3.25 M(-10.0%) |
| Sept 2015 | - | $637.00 K(-34.1%) | $3.60 M(+7.1%) |
| June 2015 | - | $967.00 K(-9.9%) | $3.37 M(+15.4%) |
| Mar 2015 | - | $1.07 M(+15.6%) | $2.92 M(+17.8%) |
| Dec 2014 | $2.48 M(-66.3%) | $928.00 K(+132.6%) | $2.48 M(-71.1%) |
| Sept 2014 | - | $399.00 K(-23.0%) | $8.57 M(+3.8%) |
| June 2014 | - | $518.00 K(-18.2%) | $8.26 M(+5.2%) |
| Mar 2014 | - | $633.00 K(-91.0%) | $7.85 M(+6.7%) |
| Dec 2013 | $7.36 M(+959.8%) | $7.02 M(+8065.1%) | $7.36 M(+2108.7%) |
| Sept 2013 | - | $86.00 K(-20.4%) | $333.00 K(+34.8%) |
| June 2013 | - | $108.00 K(-22.3%) | $247.00 K(+77.7%) |
| Mar 2013 | - | $139.00 K | $139.00 K |
| Dec 2012 | $694.00 K | - | - |
FAQ
- What is Galmed Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals annual SG&A year-on-year change?
- What is Galmed Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals quarterly SG&A year-on-year change?
- What is Galmed Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals TTM SG&A year-on-year change?
What is Galmed Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of GLMD is $3.92 M
What is the all time high annual SG&A for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high annual selling, general & administrative expenses is $7.36 M
What is Galmed Pharmaceuticals annual SG&A year-on-year change?
Over the past year, GLMD annual selling, general & administrative expenses has changed by -$733.00 K (-15.74%)
What is Galmed Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of GLMD is $1.27 M
What is the all time high quarterly SG&A for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $7.02 M
What is Galmed Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, GLMD quarterly selling, general & administrative expenses has changed by +$361.00 K (+39.58%)
What is Galmed Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of GLMD is -$779.78 M
What is the all time high TTM SG&A for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high TTM selling, general & administrative expenses is $8.57 M
What is Galmed Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, GLMD TTM selling, general & administrative expenses has changed by -$783.75 M (-19771.67%)